Package 62135-841-54

Brand: oxcarbazepine

Generic: oxcarbazepine
NDC Package

Package Facts

Identity

Package NDC 62135-841-54
Digits Only 6213584154
Product NDC 62135-841
Description

250 mL in 1 BOTTLE (62135-841-54)

Marketing

Marketing Status
Marketed Since 2024-03-27
Brand oxcarbazepine
Generic oxcarbazepine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "47e4dcae-6305-e681-e063-6294a90a5359", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0362135841546"], "unii": ["VZI5B1W380"], "rxcui": ["283536"], "spl_set_id": ["c2affa00-1d57-4d85-8db3-745191b4714d"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "20 CUP, UNIT-DOSE in 1 CARTON (62135-841-24)  / 5 mL in 1 CUP, UNIT-DOSE (62135-841-45)", "package_ndc": "62135-841-24", "marketing_start_date": "20240327"}, {"sample": false, "description": "250 mL in 1 BOTTLE (62135-841-54)", "package_ndc": "62135-841-54", "marketing_start_date": "20240327"}], "brand_name": "Oxcarbazepine", "product_id": "62135-841_47e4dcae-6305-e681-e063-6294a90a5359", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "62135-841", "generic_name": "Oxcarbazepine", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "300 mg/5mL"}], "application_number": "ANDA212428", "marketing_category": "ANDA", "marketing_start_date": "20210921", "listing_expiration_date": "20271231"}